Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration

European Journal of Pharmacology

Volumn 555, Issue 2-3, 2007, Pages 194-198

  McNamara, Ruth ^a   Maginn, Mark ^b   Harkin, Andrew ^a,c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b H LUNDBECK A S   (Denmark)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

(Rat); Caffeine; Isolated heart; MDMA; Tachycardia

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CAFFEINE; RECREATIONAL DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HYPERTHERMIA; IN VIVO STUDY; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LETHALITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG SYNERGISM; HALLUCINOGENS; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGENTS; TACHYCARDIA;

EID: 33846027055     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.10.063     Document Type: Article

References (16)

1. de la Torre R., Farre M., Roset P.N., Lopez C.H., Mas M., Ortuno J., Menoyo E., Pizarro N., Segura J., and Cami J. Pharmacology of MDMA in humans. Ann. N. Y. Acad. Sci. 914 (2000) 225-237
2. Derlet R.W., Tseng J.C., and Albertson T.E. Potentiation of cocaine and d-amphetamine toxicity with caffeine. Am. J. Emerg. Med. 10 (1992) 211-216
3. Fredholm B.B., Battig K., Holmen J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
4. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
5. Harkin A., Connor T.J., O'Donnell J.M., and Kelly J.P. Physiological and behavioral responses to stress: what does a rat find stressful?. Lab. Anim. (N. Y.) 31 (2002) 42-50
6. Harkin A., O'Donnell J.M., and Kelly J.P. A study of VitalView for behavioural and physiological monitoring in laboratory rats. Physiol. Behav. 77 (2002) 65-77
7. Lester S.J., Baggott M., Welm S., Schiller N.B., Jones R.T., Foster E., and Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann. Intern. Med. 133 (2000) 969-973
8. Mas M., Farre M., de la Torre R., Roset P.N., Ortuno J., Segura J., and Cami J. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J. Pharmacol. Exp. Ther. 290 (1999) 136-145
9. McNamara R., Kerans A., O'Neill B., and Harkin A. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). Neuropharmacology 50 (2006) 69-80
10. O'Cain P.A., Hletko S.B., Ogden B.A., and Varner K.J. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol. Behav. 70 (2000) 141-148
11. Parrott A.C. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl.) 173 (2004) 234-241
12. Sage M.D., West E.J., and Gavin J.B. Cardiac performance of isolated beating hearts obtained from rats anaesthetized by three different agents. Lab. Anim. Sci. 35 (1985) 153-155
13. Segel L.D., and Rendig S.V. Sodium pentobarbital effects on cardiac function and response to dobutamine. J. Cardiovasc. Pharmacol. 8 (1986) 392-397
14. Sondermeijer H.P., van Marle A.G., Kamen P., and Krum H. Acute effects of caffeine on heart rate variability. Am. J. Cardiol. 90 (2002) 906-907
15. Thandroyen F.T., McCarthy J., Burton K.P., and Opie L.H. Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart. Circ. Res. 62 (1988) 306-314
16. Vollenweider F.X., Gamma A., Liechti M., and Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19 (1998) 241-251